APO RESEARCH · REPORT
Marine Derived Drugs
Most marine-derived compounds possess a few defining characteristics. First, often very low doses are given to patients, and they are administered almost exclusively via intravenous infusion (i.v.). The compounds are typically large molecules, especially the depsipeptides, and they are often hydrophobic. These attributes make them fascinating compounds in terms of pharmacokinetics but also from a bioanalytical point of view.
Product & engineering
Understand the product.
Most marine-derived compounds possess a few defining characteristics. First, often very low doses are given to patients, and they are administered almost exclusively via intravenous infusion (i.v.). The compounds are typically large molecules, especially the depsipeptides, and they are often hydrophobic. These attributes make them fascinating compounds in terms of pharmacokinetics but also from a bioanalytical point of view.
The first marine-derived compound approved by the United States (US) Food and Drug Administration (FDA) was cytarabine (Cytosar U®) in 1969, followed by trabectedin (Yondelis®),eribulin mesylate (Halaven®), brentuximab vedotin (Adcetris®), and midostaurin (Rydapt®) in the years 2007, 2010, 2011, 2013, and 2017, respectively.
Selected research
Industry Research
Marine Derived Drugs Industry Research Report 2026
Market perspective
Most marine-derived compounds possess a few defining characteristics. First, often very low doses are given to patients, and they are administered almost exclusively via intravenous infusion (i.v.). The compounds are typically large molecules, especially the depsipeptides, and they are often hydrophobic. These attributes make them fascinating compounds in terms of pharmacokinetics but also from a bioanalytical point of view.
The first marine-derived compound approved by the United States (US) Food and Drug Administration (FDA) was cytarabine (Cytosar U®) in 1969, followed by trabectedin (Yondelis®),eribulin mesylate (Halaven®), brentuximab vedotin (Adcetris®), and midostaurin (Rydapt®) in the years 2007, 2010, 2011, 2013, and 2017, respectively.
Global Marine Derived Drugs key players include Seattle Genetics, Eisai Co, Tekada, Pfizer, Pharma Mar, etc. Global top five manufacturers hold a share about 85%.
Read the full market overview
North America is the largest market, with a share about 50%, followed by Europe and China, both have a share over 30 percent.
In terms of product, Mollusk is the largest segment, with a share about 50%. And in terms of application, the largest application is Antitumor Drugs, followed by Anti-Cardiovascular Drugs.
Report Scope
This report quantifies the global Marine Derived Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Marine Derived Drugs Market by Company
Seattle Genetics
Eisai Co
Tekada
Pfizer
Pharma Mar
Johnson and Johnson
GSK
TerSera Therapeutics
Teva
Marine Derived Drugs Segment by Type
Mollusk
Sponge
Tunicate
Fish
Others
Marine Derived Drugs Segment by Application
Antitumor Drugs
Anti-Cardiovascular Drugs
Others
Marine Derived Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Marine Derived Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Marine Derived Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Marine Derived Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Marine Derived Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Marine Derived Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Marine Derived Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Mollusk
- Sponge
- Tunicate
- Fish
- Others
Applications
- Antitumor Drugs
- Anti-Cardiovascular Drugs
- Others
Companies covered
- Seattle Genetics
- Eisai Co
- Tekada
- Pfizer
- Pharma Mar
- Johnson and Johnson
- GSK
- TerSera Therapeutics
- Teva
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Marine Derived Drugs Market Size (2021-2032)
- 2.2.2 Global Marine Derived Drugs Sales (2021-2032)
- 2.2.3 Global Marine Derived Drugs Market Average Price (2021-2032)
- 2.3 Marine Derived Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Mollusk
- 2.3.3 Sponge
- 2.3.4 Tunicate
- 2.3.5 Fish
- 2.3.6 Others
- 2.4 Marine Derived Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Antitumor Drugs
- 2.4.3 Anti-Cardiovascular Drugs
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Marine Derived Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Marine Derived Drugs Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Marine Derived Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Marine Derived Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Marine Derived Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Marine Derived Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Marine Derived Drugs, Product Type & Application
- 3.8 Global Manufacturers of Marine Derived Drugs, Established Date
- 3.9 Global Marine Derived Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Seattle Genetics
- 4.1.1 Seattle Genetics Company Information
- 4.1.2 Seattle Genetics Business Overview
- 4.1.3 Seattle Genetics Marine Derived Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Seattle Genetics Marine Derived Drugs Product Portfolio
- 4.1.5 Seattle Genetics Recent Developments
- 4.2 Eisai Co
- 4.2.1 Eisai Co Company Information
- 4.2.2 Eisai Co Business Overview
- 4.2.3 Eisai Co Marine Derived Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Eisai Co Marine Derived Drugs Product Portfolio
- 4.2.5 Eisai Co Recent Developments
- 4.3 Tekada
- 4.3.1 Tekada Company Information
- 4.3.2 Tekada Business Overview
- 4.3.3 Tekada Marine Derived Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Tekada Marine Derived Drugs Product Portfolio
- 4.3.5 Tekada Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Marine Derived Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Marine Derived Drugs Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 Pharma Mar
- 4.5.1 Pharma Mar Company Information
- 4.5.2 Pharma Mar Business Overview
- 4.5.3 Pharma Mar Marine Derived Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pharma Mar Marine Derived Drugs Product Portfolio
- 4.5.5 Pharma Mar Recent Developments
- 4.6 Johnson and Johnson
- 4.6.1 Johnson and Johnson Company Information
- 4.6.2 Johnson and Johnson Business Overview
- 4.6.3 Johnson and Johnson Marine Derived Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Johnson and Johnson Marine Derived Drugs Product Portfolio
- 4.6.5 Johnson and Johnson Recent Developments
- 4.7 GSK
- 4.7.1 GSK Company Information
- 4.7.2 GSK Business Overview
- 4.7.3 GSK Marine Derived Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 GSK Marine Derived Drugs Product Portfolio
- 4.7.5 GSK Recent Developments
- 4.8 TerSera Therapeutics
- 4.8.1 TerSera Therapeutics Company Information
- 4.8.2 TerSera Therapeutics Business Overview
- 4.8.3 TerSera Therapeutics Marine Derived Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 TerSera Therapeutics Marine Derived Drugs Product Portfolio
- 4.8.5 TerSera Therapeutics Recent Developments
- 4.9 Teva
- 4.9.1 Teva Company Information
- 4.9.2 Teva Business Overview
- 4.9.3 Teva Marine Derived Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Teva Marine Derived Drugs Product Portfolio
- 4.9.5 Teva Recent Developments
5 Global Marine Derived Drugs Market Scenario by Region
- 5.1 Global Marine Derived Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Marine Derived Drugs Sales by Region: 2021-2032
- 5.2.1 Global Marine Derived Drugs Sales by Region: 2021-2026
- 5.2.2 Global Marine Derived Drugs Sales by Region: 2027-2032
- 5.3 Global Marine Derived Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Marine Derived Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Marine Derived Drugs Revenue by Region: 2027-2032
- 5.4 North America Marine Derived Drugs Market Facts & Figures by Country
- 5.4.1 North America Marine Derived Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Marine Derived Drugs Sales by Country (2021-2032)
- 5.4.3 North America Marine Derived Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Marine Derived Drugs Market Facts & Figures by Country
- 5.5.1 Europe Marine Derived Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Marine Derived Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Marine Derived Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Marine Derived Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Marine Derived Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Marine Derived Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Marine Derived Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Marine Derived Drugs Market Facts & Figures by Country
- 5.7.1 South America Marine Derived Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Marine Derived Drugs Sales by Country (2021-2032)
- 5.7.3 South America Marine Derived Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Marine Derived Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Marine Derived Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Marine Derived Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Marine Derived Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Marine Derived Drugs Sales by Type (2021-2032)
- 6.1.1 Global Marine Derived Drugs Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Marine Derived Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Marine Derived Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Marine Derived Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Marine Derived Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Marine Derived Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Marine Derived Drugs Sales by Application (2021-2032)
- 7.1.1 Global Marine Derived Drugs Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Marine Derived Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Marine Derived Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Marine Derived Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Marine Derived Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Marine Derived Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Marine Derived Drugs Value Chain Analysis
- 8.1.1 Marine Derived Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Marine Derived Drugs Production Mode & Process
- 8.2 Marine Derived Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Marine Derived Drugs Distributors
- 8.2.3 Marine Derived Drugs Customers
9 Global Marine Derived Drugs Analyzing Market Dynamics
- 9.1 Marine Derived Drugs Industry Trends
- 9.2 Marine Derived Drugs Industry Drivers
- 9.3 Marine Derived Drugs Industry Opportunities and Challenges
- 9.4 Marine Derived Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst